Article Details

ULTIMATE I, ULTIMATE II studies show ublituximab decreases relapse rate in MS

Retrieved on: 2020-12-11 19:41:15

Tags for this article:

Click the tags to see associated articles and topics

ULTIMATE I, ULTIMATE II studies show ublituximab decreases relapse rate in MS. View article details on hiswai:

Excerpt

The <b>monoclonal antibody</b> also led to an ARR of less than 0.10 in each trial, with a relative decrease in ARR of approximately 60% in ULTIMATE I and 50 ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo